When filling a prescription, if a pharmacist, pharmacy intern, or terminal distributor of dangerous drugs has information indicating that the cost-sharing amount required by the patient's health benefit plan exceeds the amount that may otherwise be charged for the same drug, both of the following apply:
(A) The pharmacist, pharmacy intern, or terminal distributor shall provide this information to the patient.
(B) The patient shall not be charged the higher amount.
Added by 133rd General Assembly File No. TBD, HB 166, §101.01, eff. 10/17/2019.